When leads are not an option: Optimizing subcutaneous implantable cardioverter-defibrillator and leadless pacemaker interaction
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an effective therapy for preventing sudden cardiac death in appropriately selected patients. 1 As a fully extrathoracic and extravascular system, it avoids the risks associated with transvenous leads, such as fracture or endocarditis. 2 However, inappropriate shocks—often due to cardiac oversensing, particularly T-wave oversensing—remain a significant limitation. 3
Authors
- Paula Sánchez-Somonte (ORCID: https://orcid.org/0000-0001-5642-8100)
- Luis Muñoz‐Bellvís (ORCID: https://orcid.org/0000-0002-7809-5201)
- Sergio Castrejón‐Castrejón (ORCID: https://orcid.org/0000-0002-8032-2004)
- Omar Al Razzo
- Marcel Martínez‐Cossiani (ORCID: https://orcid.org/0000-0001-7870-9413)
- José Luís Merino (ORCID: https://orcid.org/0000-0002-1737-1903)
Institutions
- Hospital Universitario La Paz (ES)
- Hospital La Paz Institute for Health Research (ES)
Publication Details
- Journal
- HeartRhythm Case Reports
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1016/j.hrcr.2025.08.032
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00